{"schema_version":"secwatch.filing_event.v1","accession":"0001326110-24-000093","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2024-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.608715+00:00","generated_at":"2026-05-31T19:34:27.710356+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ImmunityBio settles IP lawsuit with HCW, acquires TGFb trap assets and licenses","bullets":["Settlement resolves arbitration and federal lawsuit with HCW Biologics; no monetary consideration from ImmunityBio.","ImmunityBio receives ownership of IP and drug candidates HCW9218, HCW9219, HCW9209 for TGFb-related fusion proteins.","HCW9218 is a bifunctional fusion protein (TGFb trap + IL-15) studied in Phase 1/1b trials for ovarian and pancreatic cancer.","ImmunityBio also gets exclusive license to use TF Platform for oncology targets PDL-1, IL-7, IL-12, IL-18, IL-21, plus one more.","Parties exchange mutual releases; ImmunityBio to dismiss arbitration after compliance with settlement terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001326110-24-000093","json":"https://secwatch.observer/filing/0001326110-24-000093.json","markdown":"https://secwatch.observer/filing/0001326110-24-000093.md","text":"https://secwatch.observer/filing/0001326110-24-000093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000093/0001326110-24-000093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000093/ibrx-20240713.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T19:34:27.710356+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}